FDA Adverse Event Injury Summary report: N

ADVISA DR MRI SURESCAN

MDR report key: 4160986 · Received October 10, 2014

Report

Report Number
9614453-2014-02339
Event Type
Injury
Date Received
October 10, 2014
Date of Event
July 24, 2014
Report Date
July 24, 2014
Manufacturer
IPG MFG SWITZERLAND
Product Code
NVZ
PMA / PMN Number
P980035
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
CA
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 1

PRODUCT EVENT SUMMARY: THE DEVICE WAS NOT RETURNED FOR ANALYSIS. HOWEVER, PERFORMANCE DATA COLLECTED FROM THE DEVICE WAS RECEIVED AND ANALYZED. ANALYSIS OF THE DEVICE MEMORY INDICATED PACE MODE SWITCH AND OVERSENSING INFORMATION. EGMS FROM STORED ATRIAL TACHYCARDIA (AT)/ ATRIAL FIBRILLATION (AF) EPISODES SHOW APPARENT OVERSENSING RESULTING IN MODE SWITCHES.

Additional Manufacturer Narrative · 1

IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED.

Additional Manufacturer Narrative · 1

THIS EVENT OCCURRED OUTSIDE THE US WHERE THE SAME MODEL IS DISTRIBUTED. ALL INFORMATION PROVIDED IS INCLUDED IN THIS REPORT. PATIENT INFORMATION IS NOT GENERALLY AVAILABLE DUE TO CONFIDENTIALITY CONCERNS. THIS MODEL NUMBER IS NOT APPROVED FOR DISTRIBUTION IN THE UNITED STATES; HOWEVER, IT IS SAME/SIMILAR TO A DEVICE MARKETED IN THE U.S. THIS EVENT OCCURRED OUTSIDE THE US AND PATIENT INFORMATION IS NOT GENERALLY AVAILABLE DUE TO CONFIDENTIALITY CONCERNS. (B)(4).

Description of Event or Problem · 1

IT WAS REPORTED THAT THE PATIENT WENT TO THE CLINIC AND IT WAS NOTICED THERE WAS INAPPROPRIATE MODESWITCHING. WHILE DEVICE WAS BEING REPROGRAMMED, THERE WAS T-WAVE OVERSENSING (TWOS) NOTED. THE DEVICE REMAINS IN USE. NO PATIENT COMPLICATIONS HAVE BEEN REPORTED AS A RESULT OF THIS EVENT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
642338 ADVISA DR MRI SURESCAN PULSE GENERATOR, PERMANENT, IMPLANTABLE NVZ IPG MFG SWITZERLAND A3DR01

Patients

Seq Age Sex Outcome Treatment
1 Required Intervention